Review Articles

Review of once-monthly oral ibandronate and the use thereof

T De Villiers, M Davey, B Cassim, W De Lange
South African Family Practice | Vol 59, No 4 : July/August| a4728 | DOI: https://doi.org/10.4102/safp.v59i4.4728 | ©
Submitted: 07 August 2017 | Published:

About the author(s)

T De Villiers,, South Africa
M Davey,, South Africa
B Cassim,, South Africa
W De Lange,, South Africa

Full Text:

PDF (85KB)

Share this article

Bookmark and Share

Abstract

An advisory board meeting of key opinion leaders was held in 2015 to discuss the clinical data on oral ibandronate in the treatment of postmenopausal osteoporosis.

Boniva 150 mg (ibandronate) oral once-monthly is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.1

Keywords

oral ibandronate

Metrics

Total abstract views: 303
Total article views: 208


Crossref Citations

No related citations found.